ESMO 2014

Oncology Meeting Resources

26 Sep - 30 Sep 2014, Madrid, Spain

ESMO 2014 Congress

The theme for ESMO 2014 was ‘Precision Medicine in Cancer Care.’ Whether you are a medical or surgical oncologist or a radiation oncologist, immunologist or pathologist, practising precision medicine means we are all working towards a common goal – improved patient outcomes. For your convenience and due to the large quantity of information coming from the ESMO 2014 congress, we have split the presentations up by main congress topic to allow you to find the information you need more easily.

Search through all presentations

Here, you will find the abstracts, posters, PDF presentation and webcasts from ESMO 2014 to the extent the presenters have consented to release their contribution or a slightly modified version thereof. Please, note that the publication of these presentations is a courtesy of the originating authors and is for personal educational purposes only.

Special Sessions and Tracks

Useful links





Format available

http://oncologypro.esmo.org/Meeting-Resourc...iscussant-abstracts-1183PD-1184PD-and-1557PD

Date: 27 Sep 2014
Presenter: Enriqueta Felip
Resources: Presentation, Webcast
Topic: Lung and other Thoracic Tumours

http://oncologypro.esmo.org/Meeting-Resourc...ults-from-the-phase-3-studies-ROMANA-1-and-2

Aim Cancer anorexia-cachexia syndrome is a common debilitating condition, characterized by decreased body weight, mainly lean body mass (LBM) and negatively impacts quality of life and prognosis.

Date: 27 Sep 2014
Presenter: Jennifer Temel
Resources: Abstract, Presentation, Webcast
Topics: Supportive Care, Lung and other Thoracic Tumours

http://oncologypro.esmo.org/Meeting-Resourc...al-applications-for-microRNAs-in-lung-cancer

BodyNo abstract received at time of going to press

Date: 27 Sep 2014
Presenter: Carlo Croce
Resources: Abstract, Presentation, Webcast
Topics: Lung and other Thoracic Tumours, Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...-insights-for-sequencing-data-in-lung-cancer

Body Abstract:Cases of non-small-cell lung cancer (NSCC) carrying EGFR mutations have been shown to be hyperresponive to EGFR tyrosine kinase inhibtors. Chromosomal translocations and corresponding...

Date: 28 Sep 2014
Presenter: Kazuto Nishio
Resources: Abstract, Presentation, Webcast
Topics: Lung and other Thoracic Tumours, Personalised Medicine, Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...tion-of-liver-metastasis-LM-from-lung-cancer

AimAround 30% of non-small cell lung cancer (NSCLC) patients present LM during the disease course causing a negative clinical impact on survival and quality of life.

Date: 28 Sep 2014
Presenter: Eduardo Castanon Alvarez
Resources: Abstract
Topics: Lung and other Thoracic Tumours, Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...-the-treatment-of-non-small-cell-lung-cancer

AimLung cancer is still the leading cause of cancer mortality world-wide. Erlotinib is a novel EGFR tyrosine kinase inhibitor that has shown promising results in the treatment of patients with advanced NSCLC.

Date: 28 Sep 2014
Presenter: Christoph Minichsdorfer
Resources: Abstract
Topic: Lung and other Thoracic Tumours

http://oncologypro.esmo.org/Meeting-Resourc...-resistance-in-non-small-cell-lung-carcinoma

AimNon-small cell lung cancer (NSCLC) is the leading cause of cancer-related death. NSCLC systemic treatment usually includes platinum-based chemotherapeutic drugs. Resistance to these drugs is common and multi-factorial.

Date: 28 Sep 2014
Presenter: Jair Bar
Resources: Abstract
Topics: Anti-Cancer Agents & Biologic Therapy, Basic Science, Lung and other Thoracic Tumours

http://oncologypro.esmo.org/Meeting-Resourc...cells-CTC-in-lung-cancer-Preliminary-results

AimThe value of CTC is unclear in patients (p) with lung cancer, in particular in those with locally advanced disease.MethodsBasally peripheral blood samples are been collected for prospective CTC...

Date: 28 Sep 2014
Presenter: Maria Eugenia Olmedo
Resources: Abstract
Topics: Lung and other Thoracic Tumours, Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...microRNA-signature-for-lung-cancer-detection

AimLung cancer (LC) screening using low-dose CT demonstrated a 20% reduction in lung cancer mortality in heavy smokers. However, this strategy has several limitations including high false-positive...

Date: 28 Sep 2014
Presenter: Ernest Nadal
Resources: Abstract
Topics: Lung and other Thoracic Tumours, Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...atients-with-ovarian-lung-and-breast-cancers

AimHeregulin (HRG)-driven ErbB3 signaling mediates resistance to standard-of-care (SOC) cancer therapy in a variety of preclinical models. MM-121, a HRG-blocking anti-ErbB3 antibody, underwent clinical...

Date: 28 Sep 2014
Presenter: Gavin MacBeath
Resources: Abstract
Topics: Anti-Cancer Agents & Biologic Therapy, Ovarian Cancer, Breast Cancer, Lung and other Thoracic Tumours, Translational Research